WebBioGaia AB: Year-end report January – December 2024. FOURTH QUARTER 2024 · Net sales amounted to SEK 274.3 million (206.2), an increase of SEK 68.1 million, or 33% (excluding foreign exchange effects, 19%) of which the acquisition of Nutraceutics accounted for an increase of SEK 29.9 million (15%). Organic growth was 5%. WebBioGaia AB. 7,099 followers. 2mo. Antibiotic resistance, often called the silent pandemic, killed 1.3 million people in 2024 and is expected to kill 50 million people by 2050. That is more than 12 ...
BioGaia AB (publ) (BGLAF) Stock Price Today, Quote & News
WebBioGaia AB -- -- -- 5.53% 58.75% -12.12% -21.39% 2.94% S&P 500 Total Return 11.96% 21.83% -4.38% 31.49% 18.40% 28.71% -18.11% 7.28% Calliditas Therapeutics AB -- -- -- -- -- -26.35% -31.34% 41.59% Olink Holding AB -- -- -- -- -- -- 39.45% -10.84% Abliva AB -90.14% 31.74% -59.24% -6.25% -20.00% -37.50% -86.67% 0.00% Karolinska … WebCEO is largest shareholder & each member of management team owns Sectra shares flowable activitytype
Annual Report 2024 - BioGaia
WebNov 2, 2024 · In addition to BioGaia, EQT Public Value has previously disclosed positions in Securitas, BHG Group AB, Storebrand, Adapteo and AFRY AB. Contact. Niklas Ringby, Co-Head and Investment Advisor to EQT Public Value and Partner at EQT Partners, +46 8 506 55 398. EQT Press Office, [email protected], +46 8 506 55 334. About EQT. WebApr 6, 2024 · Market Average Movement. 6.5%. 10% most volatile stocks in SE Market. 12.0%. 10% least volatile stocks in SE Market. 4.1%. Stable Share Price: BIOG B is less volatile than 75% of Swedish stocks over the past 3 months, typically moving +/- 4% a week. Volatility Over Time: BIOG B's weekly volatility (4%) has been stable over the past year. WebBioGaia AB is a healthcare company. It develops, markets and sells probiotic products. The company segmented its operating activities into three reportable segments, Pediatrics, … flowable activity 对比